semaglutide and heart health Evaluating the Cardiovascular Benefits of Innovator 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence Semaglutide and Cardiovascular Health |

Neuroprotective properties of the marine carotenoid astaxanthin and omega-3 fatty acids, and perspectives for the natural combination of both in krill oil

Some individuals may have health conditions that prevent them from achieving natural weight loss, while others are genetically predisposed to retain weight

Studies were excluded if they met the following exclusion criteria: studies conducted on children, adolescents, or animals, reviews studies, in vitro studies, editorial papers, gray literature, books, conference abstracts, and RCTs conducted without a placebo or control group

Metabolomics analyses revealed NAD + deficiency in the motor cortex

Brown, J.P., Dietrich, P.S., 1979

Per the KFF 2025 Employer Health Benefits Survey, 43% of large employer plans (5,000+ employees) cover GLP-1s for weight loss, and virtually all require prior authorization